Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial
2019 ◽
Vol 105
(5)
◽
pp. 943-947
◽
2019 ◽
Vol 105
(1)
◽
pp. S72-S73
2015 ◽
Vol 93
(3)
◽
pp. S2
◽
2012 ◽
Vol 84
(3)
◽
pp. S414
2004 ◽
Vol 60
(1)
◽
pp. S254
2019 ◽
Vol 103
(5)
◽
pp. E34
2000 ◽
Vol 48
(3)
◽
pp. 305-311
◽
Keyword(s):
2007 ◽
Vol 39
(Supplement)
◽
pp. S63
Keyword(s):
2015 ◽
Vol 5
(4)
◽
pp. 257-262
◽
2019 ◽
Vol 105
(1)
◽
pp. E54